Speciality Medicines SME IPO Live Subscription Today [Live Update]

The current overall subscription for Speciality Medicines SME is 2.33x. This indicates the total demand relative to the shares offered. Higher subscription typically suggests strong investor interest.

You can check Speciality Medicines SME subscription status on IPOwiz, BSE website, NSE website, or your broker's platform. Subscription data is updated regularly during the IPO period from 20 March 2026 to 24 March 2026.

Subscription numbers show how many times the IPO is oversubscribed. For example, 2.33x means the IPO received 2.33x times more applications than shares available. Higher subscription in retail category generally means lower allotment chances.

The subscription for Speciality Medicines SME closes on 24 March 2026. Applications must be submitted before the closing time on this date. Late applications will not be accepted.

QIB (Qualified Institutional Buyers) includes mutual funds, FIIs, and other institutions. NII (Non-Institutional Investors) includes high net-worth individuals investing above ₹2 lakh. Individual (IND) includes individual investors with applications up to ₹2 lakh. Each category has separate subscription quotas.

Higher subscription in your category means lower allotment chances. For example, if retail subscription is 2.33x, it means there are 2.33x times more applications than shares available, making allotment competitive.

The allotment for Speciality Medicines SME will be finalized and announced on 25 March 2026. You can check your allotment status on the registrar's website, BSE, NSE, or your demat account after this date.

After subscription closes on 24 March 2026, the company and registrar process all applications. Allotment is finalized by 25 March 2026, and shares are credited to successful applicants' demat accounts before the listing date on 30 March 2026.

No, you cannot apply after the subscription closes on 24 March 2026. All IPO applications must be submitted during the subscription period from 20 March 2026 to 24 March 2026. Late applications are automatically rejected.

The issue size for Speciality Medicines SME is ₹29.14 Cr, and the lot size is 1000 shares. The price range is ₹117.0 - ₹124.0. You must apply in multiples of the lot size.